https://european-biotechnology.net/wp-content/uploads/2025/08/Trump-tariff-delay_1505204883_D72asNd8o0A5y4JqjkwMtCYr3VYkAneC-e1755256098493.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-15 11:09:052025-08-15 11:09:05Trump delays 250% tariffs on non-U.S. pharmaceuticals
https://european-biotechnology.net/wp-content/uploads/2025/08/nanocelltx-1030x361-1.png
361
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-15 07:46:352025-08-15 07:46:35CPTx and NanoCell Therapeutics secure Eurostars grant to develop non-viral in-vivo CAR-T therapies
https://european-biotechnology.net/wp-content/uploads/2025/08/Pilatus-1030x658-1.jpg
658
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-14 08:52:072025-08-14 08:52:07Pilatus Biosciences Enters Clinical Collaboration with Roche
https://european-biotechnology.net/wp-content/uploads/2025/08/Kumquat-Biosciences-KRAS-Pipeline-e1755010297236.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-12 12:12:342025-08-12 17:02:07Bayer announces US$1.3bn oncology deal with Kumquat Biosciences
https://european-biotechnology.net/wp-content/uploads/2025/08/IO-Biotech-ASCO-2025-Cover-Image-e1754920785505-1030x581-1.jpg
581
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-11 14:00:262025-08-11 19:02:02IO Biotech’s cancer jab falls short in Phase 3, but Danish firm still eyes FDA approval
https://european-biotechnology.net/wp-content/uploads/2025/08/Sjogren_299197059_WsWLZnxjXMUE99D71yM8cyJKcI6Cbogx-e1755009904943.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-10 08:34:162025-08-10 08:34:16Novartis’ Ianalumab achieves Phase III endpoint in Sjögren’s syndrome
https://european-biotechnology.net/wp-content/uploads/2025/08/Dewpoint-1030x418-1.webp
418
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-08 07:19:142025-08-08 07:19:14Dewpoint Therapeutics cuts workforce, refocuses pipeline
https://european-biotechnology.net/wp-content/uploads/2025/08/EU-Biotech-Act_1299854022_oynRQWpc8YPprtvb5tO9Tcqvgwp8kDJO-e1754461928206.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-06 06:34:072025-08-06 06:34:07EU Biotech Act: Have your say!
https://european-biotechnology.net/wp-content/uploads/2025/08/Ragon-Institute-PM-e1754387379667.png
490
869
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-05 09:50:122025-08-05 09:50:12ReiThera starts study on HIV vaccine
https://european-biotechnology.net/wp-content/uploads/2025/08/Duchenne-muscular-dystrophy1.jpg-1-e1754303488131.png
888
1809
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-08-04 10:37:472025-08-04 10:37:47Imlifidase enables gene therapy in Duchenne patients with AAV antibodies
Scroll to top
